Increasing antipsychotic dose for non response in schizophrenia-Reference-Cited by-同舟云学术

Increasing antipsychotic dose for non response in schizophrenia

Published:2018-05-11 Issue:5 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Samara Myrto T¹,Klupp Elisabeth²,Helfer Bartosz¹,Rothe Philipp H¹,Schneider-Thoma Johannes¹,Leucht Stefan¹

Affiliation:

1. Technische Universität München Klinikum rechts der Isar; Klinik und Poliklinik für Psychiatrie und Psychotherapie; Ismaninger Straße 22 München Germany 81675

2. Technical University Munich; Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar; Ismaninger Str. 22 München Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011883.pub2/epdf/full

Reference134 articles.

1. High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin;Bjørndal;Psychopharmacology,1980

2. High-dose oral ziprasidone versus conventional dosing in schizophrenia patiens with residual symptoms: The ZEBRAS study;Goff;Journal of Clinical Psychopharmacology,2013

3. NCT00403546 High dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms clinicaltrials.gov/show/NCT00403546

4. AstraZeneca A Canadian, multicentre, double-blind, randomized, parallel-group study of the safety, tolerability, and efficacy of treatment with higher doses of quetiapine fumarate (Seroquel) greater than 800mg/day in schizophrenic or schizoaffective subjects Clinical Study Report CNS.000-105-629

5. A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder;Honer;Journal of Clinical Psychiatry,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of bilateral repetitive transcranial magnetic stimulation on prospective memory in patients with schizophrenia: A double‐blind randomized controlled clinical trial;Neuropsychopharmacology Reports;2023-12-06

2. Safety of Antipsychotic Polypharmacy Versus Monotherapy in a Nationwide Cohort of 61,889 Patients With Schizophrenia;American Journal of Psychiatry;2023-05-01

3. Early Antipsychotic Nonresponse as a Predictor of Nonresponse and Nonremission in Adolescents With Psychosis Treated With Aripiprazole or Quetiapine: Results From the TEA Trial;Journal of the American Academy of Child & Adolescent Psychiatry;2022-08

4. Psychopharmakologische Zwangsbehandlung im Maßregelvollzug;Forensische Psychiatrie, Psychologie, Kriminologie;2022-05-03

5. Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial;The Lancet Psychiatry;2022-04